• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同种族、经济条件不利的风湿性疾病患者治疗依从性的决定因素。

Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease.

作者信息

Garcia Popa-Lisseanu Maria G, Greisinger Anthony, Richardson Marsha, O'Malley Kimberly J, Janssen Namieta M, Marcus Donald M, Tagore Jasmeet, Suarez-Almazor Maria E

机构信息

Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.

出版信息

J Rheumatol. 2005 May;32(5):913-9.

PMID:15868630
Abstract

OBJECTIVE

To explore the determinants of adherence to medical recommendations, including drug therapy and appointment-keeping, among ethnically diverse and economically disadvantaged patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).

METHODS

Patients with RA and SLE were identified through chart review and were invited to participate in focus groups to examine their attitudes and beliefs regarding adherence to treatment and medical appointments. Eight focus groups (4 RA, 4 SLE) were conducted, with a total of 40 participants (22 SLE patients and 18 RA patients). Transcripts were analyzed using grounded theory techniques and qualitative analysis software to facilitate coding interpretation.

RESULTS

The majority of participants reported experiencing difficulty in adhering to their treatment at least occasionally. Both SLE and RA patients reported similar barriers to treatment adherence: fear of side effects, financial problems, difficulty in navigating the public health system, and perceived treatment inefficacy. RA and SLE patients also revealed barriers to appointment keeping, including difficulties in scheduling, financial costs, transportation, and functional impairment limiting their ability to attend the clinic.

CONCLUSION

Patients' perceptions of and experiences with the health system, physicians, medication effectiveness, and side effects influence their adherence to treatment and other medical recommendations. Strategies to improve adherence could include the following: attempting to modify patients' beliefs and perceptions regarding medication effectiveness, promoting realistic expectations about risk/benefit ratios, and improving access to health care by reducing barriers that limit the interaction between patients and the health system.

摘要

目的

探讨在患有类风湿性关节炎(RA)和系统性红斑狼疮(SLE)的不同种族且经济处于不利地位的患者中,坚持药物治疗和按时就诊等医疗建议的决定因素。

方法

通过病历审查确定患有RA和SLE的患者,并邀请他们参加焦点小组,以检查他们对坚持治疗和按时就诊的态度及信念。共进行了8个焦点小组(4个RA组,4个SLE组),共有40名参与者(22名SLE患者和18名RA患者)。使用扎根理论技术和定性分析软件对转录本进行分析,以促进编码解释。

结果

大多数参与者报告至少偶尔在坚持治疗方面存在困难。SLE和RA患者报告的治疗依从性障碍相似:对副作用的恐惧、经济问题、在公共卫生系统中就医困难以及认为治疗无效。RA和SLE患者还揭示了按时就诊的障碍,包括安排时间困难、经济成本、交通问题以及功能障碍限制了他们前往诊所就诊的能力。

结论

患者对医疗系统、医生、药物疗效和副作用的认知及体验会影响他们对治疗和其他医疗建议的依从性。提高依从性的策略可包括以下方面:尝试改变患者对药物疗效的信念和认知,促进对风险/效益比的现实期望,并通过减少限制患者与医疗系统互动的障碍来改善医疗服务的可及性。

相似文献

1
Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease.不同种族、经济条件不利的风湿性疾病患者治疗依从性的决定因素。
J Rheumatol. 2005 May;32(5):913-9.
2
Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs.类风湿关节炎患者使用改善病情抗风湿药的依从率及其与不依从的关系。
J Rheumatol. 2009 Oct;36(10):2164-70. doi: 10.3899/jrheum.081204. Epub 2009 Sep 1.
3
Adherence to medications in systemic lupus erythematosus.系统性红斑狼疮患者的药物依从性。
J Clin Rheumatol. 2008 Aug;14(4):195-201. doi: 10.1097/RHU.0b013e31817a242a.
4
Initiation of disease-modifying antirheumatic drug therapy in minority and disadvantaged patients with rheumatoid arthritis.在少数族裔和处境不利的类风湿关节炎患者中启动改善病情抗风湿药物治疗
J Rheumatol. 2007 Dec;34(12):2400-7. Epub 2007 Nov 1.
5
Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus.类风湿关节炎和系统性红斑狼疮患者中代谢综合征的患病率及相关因素
J Clin Rheumatol. 2008 Apr;14(2):74-7. doi: 10.1097/RHU.0b013e31816b2faa.
6
Factors influencing adherence to medications in a group of patients with systemic lupus erythematosus in Jamaica.牙买加一组系统性红斑狼疮患者用药依从性的影响因素
Lupus. 2008 Aug;17(8):761-9. doi: 10.1177/0961203308089404.
7
Intentional and unintentional treatment nonadherence in patients with systemic lupus erythematosus.系统性红斑狼疮患者的故意和非故意治疗不依从。
Arthritis Care Res (Hoboken). 2011 Mar;63(3):342-50. doi: 10.1002/acr.20411. Epub 2010 Nov 30.
8
Out-of-pocket expenses and their burden in patients with rheumatoid arthritis.类风湿关节炎患者的自付费用及其负担
Arthritis Rheum. 2009 Nov 15;61(11):1563-70. doi: 10.1002/art.24724.
9
Making the rheumatologist aware of patients' non-adherence does not improve medication adherence in patients with rheumatoid arthritis.让风湿病专家了解患者的不依从并不会改善类风湿关节炎患者的药物依从性。
Scand J Rheumatol. 2011 May;40(3):192-6. doi: 10.3109/03009742.2010.517214. Epub 2010 Oct 26.
10
The risk of lymphoma development in autoimmune diseases: a meta-analysis.自身免疫性疾病中淋巴瘤发生的风险:一项荟萃分析。
Arch Intern Med. 2005 Nov 14;165(20):2337-44. doi: 10.1001/archinte.165.20.2337.

引用本文的文献

1
From image to insight: leveraging imaging to empower patients with inflammatory arthropathies.从图像到洞察:利用成像技术赋能炎性关节病患者。
Front Med (Lausanne). 2025 Aug 8;12:1630114. doi: 10.3389/fmed.2025.1630114. eCollection 2025.
2
Relationship between hydroxychloroquine blood levels and lupus activity through the lens of the type 1 and type 2 lupus model: a cross-sectional study.从1型和2型狼疮模型角度看羟氯喹血药浓度与狼疮活动度的关系:一项横断面研究
Lupus Sci Med. 2025 Jun 30;12(1):e001531. doi: 10.1136/lupus-2025-001531.
3
Implementation outcomes of a patient decision-aid in a diverse population with systemic lupus erythematosus in 15 US rheumatology clinics.
美国15家风湿病诊所中,针对患有系统性红斑狼疮的不同人群的患者决策辅助工具的实施效果。
Rheumatology (Oxford). 2025 Aug 1;64(8):4631-4640. doi: 10.1093/rheumatology/keaf205.
4
Time required to implement a computerized patient decision aid for lupus in outpatient visits.在门诊就诊中实施狼疮患者计算机决策辅助工具所需的时间。
Implement Sci Commun. 2025 Apr 10;6(1):41. doi: 10.1186/s43058-025-00727-8.
5
Frequency and factors associated with loss to follow-up in newly diagnosed rheumatoid arthritis patient: a single-centre study.新诊断类风湿关节炎患者失访的频率及相关因素:一项单中心研究
Reumatologia. 2024;62(6):405-411. doi: 10.5114/reum/194158. Epub 2024 Dec 24.
6
A real-world analysis of pharmacotherapy adherence and the factors influencing it in Serbia: a nationwide, population-based, cross-sectional study.塞尔维亚真实世界药物治疗依从性及其影响因素的分析:一项全国性、基于人群的、横断面研究。
Front Public Health. 2024 Aug 1;12:1437796. doi: 10.3389/fpubh.2024.1437796. eCollection 2024.
7
Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey.与系统性红斑狼疮患者药物治疗不依从相关的因素:来自瑞典调查的结果。
Lupus. 2024 May;33(6):615-628. doi: 10.1177/09612033241242692. Epub 2024 Mar 28.
8
Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network.在参加AMP RA/SLE狼疮性肾炎网络研究的患者中,肾外症状与较差的生活质量相关。
Rheumatology (Oxford). 2025 Mar 1;64(3):1193-1200. doi: 10.1093/rheumatology/keae189.
9
A qualitative study of facilitators of medication adherence in systemic lupus erythematosus: Perspectives from rheumatology providers/staff and patients.一项关于系统性红斑狼疮患者药物依从性促进因素的定性研究:来自风湿病学提供者/工作人员和患者的观点。
Lupus. 2024 Feb;33(2):137-144. doi: 10.1177/09612033231225843. Epub 2024 Jan 2.
10
The efficacy of immunosuppressive drugs induction therapy for lupus nephritis: a systematic review and network meta-analysis.免疫抑制药物诱导治疗狼疮性肾炎的疗效:系统评价和网络荟萃分析。
Ren Fail. 2023;45(2):2290365. doi: 10.1080/0886022X.2023.2290365. Epub 2023 Dec 12.